Multiple Sclerosis Research Begins With You
A worldwide team of researchers is conducting the clinical research study described on this website. They are evaluating an investigational oral medication for RMS. Other currently marketed treatments for RMS require injection.
There are 2.5 million people worldwide facing some form of multiple sclerosis (MS). Relapsing multiple sclerosis (RMS) is the most common initial diagnosis affecting more than 85% of the MS population. Currently, there is no cure for RMS. But treatments that can change the course of the disease have been introduced in recent years. The future is made even more hopeful knowing that research is being done around the world to better understand this disease.
This web site describes a clinical research study for people 18 to 55 years old with RMS. Here you can learn more about the study and how you may qualify to participate.